MET and non-small cell lung carcinoma: A separate EGFRM+ NSCLC in our cohort exhibited the unusual combination of two rare exon 19 mutations, the microdeletion E746_R748del and the substitution A750P, together with the p.T1010I point-mutation in the MET-gene [51].